XML 40 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Income (Loss) per Common Share
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net Income (Loss) per Common Share
Note 11 - Net Income (Loss) per Common Share
The following table presents a reconciliation of net income (loss) and the shares used in calculating weighted average basic and diluted earnings per common share for the years ended December 31, 2023, December 31, 2022 and December 31, 2021.
 For the Years Ended
 December 31, 2023December 31, 2022December 31, 2021
Net Income (Loss)$(67,923)$(229,930)$15,363 
Less: Preferred dividends(11,982)(11,982)(11,473)
Net Income (loss) available (related) to common stockholders$(79,905)$(241,912)$3,890 
Weighted average common shares outstanding – basic43,054 23,594 15,897 
Add: Effect of dilutive non-vested awards, assumed vested— — 165 
Weighted average common shares outstanding – diluted43,054 23,594 16,062 
For the years ended December 31, 2023 and December 31, 2022, 298 and 114, respectively, of potentially dilutive non-vested awards outstanding were excluded from the computation of diluted Net Loss related to common stockholders because to have included them would have been anti-dilutive for the period.
Note 12 - Comprehensive Income (Loss) per Common Share
The following table presents a reconciliation of comprehensive loss and the shares used in calculating weighted average basic and diluted comprehensive loss per common share for the years ended December 31, 2023, December 31, 2022 and December 31, 2021.
 For the Years Ended
 December 31, 2023December 31, 2022December 31, 2021
Comprehensive Loss$(56,396)$(348,430)$(56,695)
Less: Preferred dividends(11,982)(11,982)(11,473)
Comprehensive Loss related to common stockholders$(68,378)$(360,412)$(68,168)
Comprehensive Loss per share related to common stockholders:
Basic$(1.59)$(15.28)$(4.29)
Diluted$(1.59)$(15.28)$(4.29)
Weighted average common shares outstanding:
Basic43,054 23,594 15,897 
Add: Effect of dilutive non-vested awards, assumed vested— — — 
Diluted43,054 23,594 15,897 
For the years ended December 31, 2023, December 31, 2022 and December 31, 2021, 298, 114 and 165 of potentially dilutive non-vested awards outstanding were excluded from the computation of diluted Comprehensive Loss related to common stockholders because to have included them would have been anti-dilutive for the period.